= 0 1 0 1 O
< 1 2 1 2 O
0.6 3 6 3 6 B-upper_bound
mg 7 9 7 9 I-upper_bound
/ 9 10 9 10 I-upper_bound
dL 10 12 10 12 I-upper_bound
( 13 14 13 14 O
patients 14 22 14 22 O
age 23 26 23 26 B-age
1 27 28 27 28 B-lower_bound
to 29 31 29 31 O
< 32 33 32 33 O
2 34 35 34 35 B-upper_bound
years 36 41 36 41 I-upper_bound
) 41 42 41 42 O

= 0 1 43 44 O
< 1 2 44 45 O
0.8 3 6 46 49 B-upper_bound
mg 7 9 50 52 I-upper_bound
/ 9 10 52 53 I-upper_bound
dL 10 12 53 55 I-upper_bound
( 13 14 56 57 O
patients 14 22 57 65 O
age 23 26 66 69 B-age
2 27 28 70 71 B-lower_bound
to 29 31 72 74 O
< 32 33 75 76 O
6 34 35 77 78 B-upper_bound
years 36 41 79 84 I-upper_bound
) 41 42 84 85 O

= 0 1 86 87 O
< 1 2 87 88 O
1 3 4 89 90 B-upper_bound
mg 5 7 91 93 I-upper_bound
/ 7 8 93 94 I-upper_bound
dL 8 10 94 96 I-upper_bound
( 11 12 97 98 O
patients 12 20 98 106 O
age 21 24 107 110 B-age
6 25 26 111 112 B-lower_bound
to 27 29 113 115 O
< 30 31 116 117 O
10 32 34 118 120 B-upper_bound
years 35 40 121 126 I-upper_bound
) 40 41 126 127 O

= 0 1 128 129 O
< 1 2 129 130 O
1.2 3 6 131 134 B-upper_bound
mg 7 9 135 137 I-upper_bound
/ 9 10 137 138 I-upper_bound
dL 10 12 138 140 I-upper_bound
( 13 14 141 142 O
patients 14 22 142 150 O
age 23 26 151 154 B-age
10 27 29 155 157 B-lower_bound
to 30 32 158 160 O
< 33 34 161 162 O
13 35 37 163 165 B-upper_bound
years 38 43 166 171 I-upper_bound
) 43 44 171 172 O

= 0 1 173 174 O
< 1 2 174 175 O
1.4 3 6 176 179 B-upper_bound
mg 7 9 180 182 I-upper_bound
/ 9 10 182 183 I-upper_bound
dL 10 12 183 185 I-upper_bound
( 13 14 186 187 O
female 14 20 187 193 B-gender
patients 21 29 194 202 I-gender
age 30 33 203 206 B-age
> 34 35 207 208 O
= 35 36 208 209 O
13 37 39 210 212 B-lower_bound
years 40 45 213 218 I-lower_bound
) 45 46 218 219 O

= 0 1 220 221 O
< 1 2 221 222 O
1.5 3 6 223 226 B-upper_bound
mg 7 9 227 229 I-upper_bound
/ 9 10 229 230 I-upper_bound
dL 10 12 230 232 I-upper_bound
( 13 14 233 234 O
male 14 18 234 238 B-gender
patients 19 27 239 247 I-gender
age 28 31 248 251 B-age
13 32 34 252 254 B-lower_bound
to 35 37 255 257 O
< 38 39 258 259 O
16 40 42 260 262 B-upper_bound
years 43 48 263 268 I-upper_bound
) 48 49 268 269 O

= 0 1 270 271 O
< 1 2 271 272 O
1.7 3 6 273 276 B-upper_bound
mg 7 9 277 279 I-upper_bound
/ 9 10 279 280 I-upper_bound
dL 10 12 280 282 I-upper_bound
( 13 14 283 284 O
male 14 18 284 288 B-gender
patients 19 27 289 297 I-gender
age 28 31 298 301 B-age
> 32 33 302 303 O
= 33 34 303 304 O
16 35 37 305 307 B-lower_bound
years 38 43 308 313 I-lower_bound
) 43 44 313 314 O

A 0 1 315 316 O
serum 2 7 317 322 B-treatment
creatinine 8 18 323 333 I-treatment
based 19 24 334 339 O
on 25 27 340 342 O
age 28 31 343 346 B-age
/ 31 32 346 347 O
gender 32 38 347 353 O

Anti 0 4 354 358 B-treatment
- 4 5 358 359 I-treatment
cancer 5 11 359 365 I-treatment
agents 12 18 366 372 I-treatment
: 18 19 372 373 O
Patients 20 28 374 382 O
who 29 32 383 386 O
are 33 36 387 390 O
currently 37 46 391 400 O
receiving 47 56 401 410 O
other 57 62 411 416 O
anti 63 67 417 421 B-treatment
- 67 68 421 422 I-treatment
cancer 68 74 422 428 I-treatment
agents 75 81 429 435 I-treatment

Antibodies 0 10 436 446 O
: 10 11 446 447 O
> 12 13 448 449 O
= 13 14 449 450 O
21 15 17 451 453 B-lower_bound
days 18 22 454 458 I-lower_bound
must 23 27 459 463 O
have 28 32 464 468 O
elapsed 33 40 469 476 O
from 41 45 477 481 O
infusion 46 54 482 490 O
of 55 57 491 493 O
last 58 62 494 498 O
dose 63 67 499 503 O
of 68 70 504 506 O
antibody 71 79 507 515 O
, 79 80 515 516 O
and 81 84 517 520 O
toxicity 85 93 521 529 B-clinical_variable
related 94 101 530 537 O
to 102 104 538 540 O
prior 105 110 541 546 B-treatment
antibody 111 119 547 555 I-treatment
therapy 120 127 556 563 I-treatment
must 128 132 564 568 O
be 133 135 569 571 O
recovered 136 145 572 581 O
to 146 148 582 584 O
grade 149 154 585 590 O
= 155 156 591 592 O
< 156 157 592 593 O
1 158 159 594 595 O

Biologic 0 8 596 604 B-treatment
( 9 10 605 606 I-treatment
anti 10 14 606 610 I-treatment
- 14 15 610 611 I-treatment
neoplastic 15 25 611 621 I-treatment
agent 26 31 622 627 I-treatment
): 31 33 627 629 I-treatment
At 34 36 630 632 O
least 37 42 633 638 O
7 43 44 639 640 B-lower_bound
days 45 49 641 645 I-lower_bound
after 50 55 646 651 I-lower_bound
the 56 59 652 655 O
last 60 64 656 660 B-treatment
dose 65 69 661 665 I-treatment
of 70 72 666 668 I-treatment
a 73 74 669 670 I-treatment
biologic 75 83 671 679 I-treatment
agent 84 89 680 685 I-treatment

Concomitant 0 11 686 697 B-treatment
medications 12 23 698 709 I-treatment

Corticosteroids 0 15 710 725 B-treatment
: 15 16 725 726 O
If 17 19 727 729 O
used 20 24 730 734 O
to 25 27 735 737 O
modify 28 34 738 744 O
immune 35 41 745 751 O
adverse 42 49 752 759 O
events 50 56 760 766 O
related 57 64 767 774 O
to 65 67 775 777 O
prior 68 73 778 783 B-treatment
therapy 74 81 784 791 I-treatment
, 81 82 791 792 O
> 83 84 793 794 O
= 84 85 794 795 O
14 86 88 796 798 B-lower_bound
days 89 93 799 803 I-lower_bound
must 94 98 804 808 O
have 99 103 809 813 O
elapsed 104 111 814 821 O
since 112 117 822 827 O
last 118 122 828 832 O
dose 123 127 833 837 O
of 128 130 838 840 O
corticosteroid 131 145 841 855 B-treatment

Corticosteroids 0 15 856 871 B-treatment
: 15 16 871 872 O
Patients 17 25 873 881 O
receiving 26 35 882 891 O
corticosteroids 36 51 892 907 B-treatment
who 52 55 908 911 O
have 56 60 912 916 O
not 61 64 917 920 O
been 65 69 921 925 O
on 70 72 926 928 O
a 73 74 929 930 O
stable 75 81 931 937 O
or 82 84 938 940 O
decreasing 85 95 941 951 O
dose 96 100 952 956 O
of 101 103 957 959 O
corticosteroid 104 118 960 974 O
for 119 122 975 978 O
at 123 125 979 981 O
least 126 131 982 987 O
7 132 133 988 989 B-lower_bound
days 134 138 990 994 I-lower_bound
prior 139 144 995 1000 I-lower_bound
to 145 147 1001 1003 O
enrollment 148 158 1004 1014 O

Creatinine 0 10 1015 1025 B-clinical_variable
clearance 11 20 1026 1035 I-clinical_variable
or 21 23 1036 1038 O
radioisotope 24 36 1039 1051 B-clinical_variable
glomerular 37 47 1052 1062 I-clinical_variable
filtration 48 58 1063 1073 I-clinical_variable
rate 59 63 1074 1078 I-clinical_variable
( 64 65 1079 1080 I-clinical_variable
GFR 65 68 1080 1083 I-clinical_variable
) 68 69 1083 1084 I-clinical_variable
> 70 71 1085 1086 O
= 71 72 1086 1087 O
70 73 75 1088 1090 B-lower_bound
ml 76 78 1091 1093 I-lower_bound
/ 78 79 1093 1094 I-lower_bound
min/1.73 79 87 1094 1102 I-lower_bound
m^2 88 91 1103 1106 I-lower_bound

External 0 8 1107 1115 B-treatment
beam 9 13 1116 1120 I-treatment
radiation 14 23 1121 1130 I-treatment
therapy 24 31 1131 1138 I-treatment
( 32 33 1139 1140 I-treatment
XRT 33 36 1140 1143 I-treatment
): 36 38 1143 1145 I-treatment
At 39 41 1146 1148 O
least 42 47 1149 1154 O
14 48 50 1155 1157 B-lower_bound
days 51 55 1158 1162 I-lower_bound
after 56 61 1163 1168 O
local 62 67 1169 1174 O
palliative 68 78 1175 1185 B-treatment
XRT 79 82 1186 1189 I-treatment
( 83 84 1190 1191 O
small 84 89 1191 1196 O
port 90 94 1197 1201 O
) 94 95 1201 1202 O

Hematopoietic 0 13 1203 1216 O
growth 14 20 1217 1223 O
factors 21 28 1224 1231 O
: 28 29 1231 1232 O
At 30 32 1233 1235 O
least 33 38 1236 1241 O
14 39 41 1242 1244 B-lower_bound
days 42 46 1245 1249 I-lower_bound
after 47 52 1250 1255 I-lower_bound
the 53 56 1256 1259 O
last 57 61 1260 1264 O
dose 62 66 1265 1269 O
of 67 69 1270 1272 O
a 70 71 1273 1274 O
long 72 76 1275 1279 O
- 76 77 1279 1280 O
acting 77 83 1280 1286 O
growth 84 90 1287 1293 O
factor 91 97 1294 1300 O
( 98 99 1301 1302 O
e.g. 99 103 1302 1306 O
Neulasta 104 112 1307 1315 B-treatment
) 112 113 1315 1316 O
or 114 116 1317 1319 O
7 117 118 1320 1321 B-lower_bound
days 119 123 1322 1326 I-lower_bound
for 124 127 1327 1330 O
short 128 133 1331 1336 O
- 133 134 1336 1337 O
acting 134 140 1337 1343 O
growth 141 147 1344 1350 O
factor 148 154 1351 1357 O

Hemoglobin 0 10 1358 1368 B-clinical_variable
> 11 12 1369 1370 O
= 12 13 1370 1371 O
8.0 14 17 1372 1375 B-lower_bound
g 18 19 1376 1377 I-lower_bound
/ 19 20 1377 1378 I-lower_bound
dL 20 22 1378 1380 I-lower_bound
at 23 25 1381 1383 O
baseline 26 34 1384 1392 O
( 35 36 1393 1394 O
may 36 39 1394 1397 O
receive 40 47 1398 1405 O
red 48 51 1406 1409 B-treatment
blood 52 57 1410 1415 I-treatment
cell 58 62 1416 1420 I-treatment
[ 63 64 1421 1422 I-treatment
RBC 64 67 1422 1425 I-treatment
] 67 68 1425 1426 I-treatment
transfusions 69 81 1427 1439 I-treatment
) 81 82 1439 1440 O

Immunotherapy 0 13 1441 1454 B-treatment
: 13 14 1454 1455 O
At 15 17 1456 1458 O
least 18 23 1459 1464 O
42 24 26 1465 1467 B-lower_bound
days 27 31 1468 1472 I-lower_bound
after 32 37 1473 1478 I-lower_bound
the 38 41 1479 1482 O
completion 42 52 1483 1493 O
of 53 55 1494 1496 O
any 56 59 1497 1500 O
type 60 64 1501 1505 O
of 65 67 1506 1508 O
immunotherapy 68 81 1509 1522 B-treatment
, 81 82 1522 1523 O
e.g. 83 87 1524 1528 O
tumor 88 93 1529 1534 B-treatment
vaccines 94 102 1535 1543 I-treatment

Investigational 0 15 1544 1559 B-treatment
drugs 16 21 1560 1565 I-treatment
: 21 22 1565 1566 O
Patients 23 31 1567 1575 O
who 32 35 1576 1579 O
are 36 39 1580 1583 O
currently 40 49 1584 1593 O
receiving 50 59 1594 1603 O
another 60 67 1604 1611 O
investigational 68 83 1612 1627 B-treatment
drug 84 88 1628 1632 I-treatment

Karnofsky 0 9 1633 1642 B-clinical_variable
> 10 11 1643 1644 O
= 11 12 1644 1645 O
50 13 15 1646 1648 B-lower_bound
% 15 16 1648 1649 I-lower_bound
for 17 20 1650 1653 O
patients 21 29 1654 1662 O
> 30 31 1663 1664 O
16 32 34 1665 1667 O
years 35 40 1668 1673 O
of 41 43 1674 1676 O
age 44 47 1677 1680 B-age
and 48 51 1681 1684 O
Lansky 52 58 1685 1691 B-clinical_variable
> 59 60 1692 1693 O
= 60 61 1693 1694 O
50 62 64 1695 1697 O
for 65 68 1698 1701 O
patients 69 77 1702 1710 O
= 78 79 1711 1712 O
< 79 80 1712 1713 O
16 81 83 1714 1716 O
years 84 89 1717 1722 O
of 90 92 1723 1725 O
age 93 96 1726 1729 O

Myelosuppressive 0 16 1730 1746 B-treatment
chemotherapy 17 29 1747 1759 I-treatment
: 29 30 1759 1760 O
At 31 33 1761 1763 O
least 34 39 1764 1769 O
21 40 42 1770 1772 B-lower_bound
days 43 47 1773 1777 I-lower_bound
after 48 53 1778 1783 I-lower_bound
the 54 57 1784 1787 O
last 58 62 1788 1792 O
dose 63 67 1793 1797 O
of 68 70 1798 1800 O
myelosuppressive 71 87 1801 1817 B-treatment
chemotherapy 88 100 1818 1830 I-treatment
( 101 102 1831 1832 O
42 102 104 1832 1834 B-lower_bound
days 105 109 1835 1839 I-lower_bound
if 110 112 1840 1842 O
prior 113 118 1843 1848 O
nitrosourea 119 130 1849 1860 B-treatment
) 130 131 1860 1861 O

Part 0 4 1862 1866 O
A 5 6 1867 1868 O
: 6 7 1868 1869 O
Patients 8 16 1870 1878 O
with 17 21 1879 1883 O
recurrent 22 31 1884 1893 O
or 32 34 1894 1896 O
refractory 35 45 1897 1907 O
solid 46 51 1908 1913 B-cancer
tumors 52 58 1914 1920 I-cancer
, 58 59 1920 1921 O
including 60 69 1922 1931 O
lymphoma 70 78 1932 1940 B-cancer
and 79 82 1941 1944 O
CNS 83 86 1945 1948 B-cancer
tumors 87 93 1949 1955 I-cancer

Part 0 4 1956 1960 O
B 5 6 1961 1962 O
: 6 7 1962 1963 O
Patients 8 16 1964 1972 O
with 17 21 1973 1977 O
recurrent 22 31 1978 1987 O
or 32 34 1988 1990 O
refractory 35 45 1991 2001 O
high 46 50 2002 2006 O
grade 51 56 2007 2012 O
glioma 57 63 2013 2019 B-cancer
( 64 65 2020 2021 O
World 65 70 2021 2026 O
Health 71 77 2027 2033 O
Organization 78 90 2034 2046 O
[ 91 92 2047 2048 O
WHO 92 95 2048 2051 O
] 95 96 2051 2052 O
grade 97 102 2053 2058 O
III 103 106 2059 2062 O
/ 106 107 2062 2063 O
IV 107 109 2063 2065 O
) 109 110 2065 2066 O
including 111 120 2067 2076 O
disseminated 121 133 2077 2089 O
tumors 134 140 2090 2096 B-cancer
( 141 142 2097 2098 O
excluding 142 151 2098 2107 O
diffuse 152 159 2108 2115 B-cancer
intrinsic 160 169 2116 2125 I-cancer
pontine 170 177 2126 2133 I-cancer
glioma 178 184 2134 2140 I-cancer
[ 185 186 2141 2142 I-cancer
DIPG 186 190 2142 2146 I-cancer
] 190 191 2146 2147 I-cancer
) 191 192 2147 2148 O
, 192 193 2148 2149 O
not 194 197 2150 2153 O
requiring 198 207 2154 2163 O
surgical 208 216 2164 2172 B-treatment
resection 217 226 2173 2182 I-treatment

Part 0 4 2183 2187 O
C 5 6 2188 2189 O
: 6 7 2189 2190 O
Archived 8 16 2191 2199 O
paraffin 17 25 2200 2208 O
- 25 26 2208 2209 O
embedded 26 34 2209 2217 O
tissue 35 41 2218 2224 O
( 42 43 2225 2226 O
20 43 45 2226 2228 O
unstained 46 55 2229 2238 O
slides 56 62 2239 2245 O
or 63 65 2246 2248 O
a 66 67 2249 2250 O
tumor 68 73 2251 2256 B-cancer
block 74 79 2257 2262 O
) 79 80 2262 2263 O
from 81 85 2264 2268 O
a 86 87 2269 2270 O
prior 88 93 2271 2276 O
resection 94 103 2277 2286 O
must 104 108 2287 2291 O
be 109 111 2292 2294 O
available 112 121 2295 2304 O
as 122 124 2305 2307 O
a 125 126 2308 2309 O
control 127 134 2310 2317 O
for 135 138 2318 2321 O
correlative 139 150 2322 2333 O
studies 151 158 2334 2341 O

Part 0 4 2342 2346 O
C 5 6 2347 2348 O
: 6 7 2348 2349 O
Patients 8 16 2350 2358 O
with 17 21 2359 2363 O
recurrent 22 31 2364 2373 O
or 32 34 2374 2376 O
refractory 35 45 2377 2387 O
high 46 50 2388 2392 O
grade 51 56 2393 2398 O
glioma 57 63 2399 2405 B-cancer
( 64 65 2406 2407 O
WHO 65 68 2407 2410 O
grade 69 74 2411 2416 O
III 75 78 2417 2420 O
/ 78 79 2420 2421 O
IV 79 81 2421 2423 O
) 81 82 2423 2424 O
and 83 86 2425 2428 O
requiring 87 96 2429 2438 O
surgical 97 105 2439 2447 B-treatment
resection 106 115 2448 2457 I-treatment
( 116 117 2458 2459 O
excluding 117 126 2459 2468 O
DIPG 127 131 2469 2473 B-cancer
and 132 135 2474 2477 O
disseminated 136 148 2478 2490 B-cancer
tumors 149 155 2491 2497 I-cancer
) 155 156 2497 2498 O
, 156 157 2498 2499 O
who 158 161 2500 2503 O
in 162 164 2504 2506 O
the 165 168 2507 2510 O
opinion 169 176 2511 2518 O
of 177 179 2519 2521 O
treating 180 188 2522 2530 O
physicians 189 199 2531 2541 O
, 199 200 2541 2542 O
are 201 204 2543 2546 O
medically 205 214 2547 2556 O
stable 215 221 2557 2563 O
to 222 224 2564 2566 O
receive 225 232 2567 2574 O
3 233 234 2575 2576 B-lower_bound
- 234 235 2576 2577 O
4 235 236 2577 2578 B-upper_bound
doses 237 242 2579 2584 O
of 243 245 2585 2587 O
selinexor 246 255 2588 2597 O
( 256 257 2598 2599 O
8 257 258 2599 2600 B-lower_bound
- 258 259 2600 2601 O
10 259 261 2601 2603 B-upper_bound
days 262 266 2604 2608 I-upper_bound
of 267 269 2609 2611 O
treatment 270 279 2612 2621 B-treatment
) 279 280 2621 2622 O
before 281 287 2623 2629 O
undergoing 288 298 2630 2640 O
surgery 299 306 2641 2648 B-treatment
without 307 314 2649 2656 O
compromising 315 327 2657 2669 O
the 328 331 2670 2673 O
success 332 339 2674 2681 O
of 340 342 2682 2684 O
the 343 346 2685 2688 O
procedure 347 356 2689 2698 O

Parts 0 5 2699 2704 O
B 6 7 2705 2706 O
and 8 11 2707 2710 O
C 12 13 2711 2712 O
: 13 14 2712 2713 O
Patients 15 23 2714 2722 O
must 24 28 2723 2727 O
have 29 33 2728 2732 O
measurable 34 44 2733 2743 O
disease 45 52 2744 2751 O
on 53 55 2752 2754 O
imaging 56 63 2755 2762 B-treatment

Patient?s 0 9 2763 2772 O
current 10 17 2773 2780 O
disease 18 25 2781 2788 O
state 26 31 2789 2794 O
must 32 36 2795 2799 O
be 37 39 2800 2802 O
one 40 43 2803 2806 O
for 44 47 2807 2810 O
which 48 53 2811 2816 O
there 54 59 2817 2822 O
is 60 62 2823 2825 O
no 63 65 2826 2828 O
known 66 71 2829 2834 O
curative 72 80 2835 2843 B-treatment
therapy 81 88 2844 2851 I-treatment
or 89 91 2852 2854 O
therapy 92 99 2855 2862 O
proven 100 106 2863 2869 O
to 107 109 2870 2872 O
prolong 110 117 2873 2880 O
survival 118 126 2881 2889 O
with 127 131 2890 2894 O
an 132 134 2895 2897 O
acceptable 135 145 2898 2908 O
quality 146 153 2909 2916 O
of 154 156 2917 2919 O
life 157 161 2920 2924 O

Patients 0 8 2925 2933 O
must 9 13 2934 2938 O
have 14 18 2939 2943 O
a 19 20 2944 2945 O
body 21 25 2946 2950 B-clinical_variable
surface 26 33 2951 2958 I-clinical_variable
area 34 38 2959 2963 I-clinical_variable
( 39 40 2964 2965 I-clinical_variable
BSA 40 43 2965 2968 I-clinical_variable
) 43 44 2968 2969 I-clinical_variable
> 45 46 2970 2971 O
= 46 47 2971 2972 O
0.84 48 52 2973 2977 B-lower_bound
m^2 53 56 2978 2981 I-lower_bound

Patients 0 8 2982 2990 O
must 9 13 2991 2995 O
have 14 18 2996 3000 O
fully 19 24 3001 3006 O
recovered 25 34 3007 3016 O
from 35 39 3017 3021 O
the 40 43 3022 3025 O
acute 44 49 3026 3031 O
toxic 50 55 3032 3037 O
effects 56 63 3038 3045 O
of 64 66 3046 3048 O
all 67 70 3049 3052 O
prior 71 76 3053 3058 B-treatment
anti 77 81 3059 3063 I-treatment
- 81 82 3063 3064 I-treatment
cancer 82 88 3064 3070 I-treatment
therapy 89 96 3071 3078 I-treatment
and 97 100 3079 3082 O
must 101 105 3083 3087 O
meet 106 110 3088 3092 O
the 111 114 3093 3096 O
following 115 124 3097 3106 O
minimum 125 132 3107 3114 O
duration 133 141 3115 3123 O
from 142 146 3124 3128 O
prior 147 152 3129 3134 B-treatment
anti 153 157 3135 3139 I-treatment
- 157 158 3139 3140 I-treatment
cancer 158 164 3140 3146 I-treatment
directed 165 173 3147 3155 I-treatment
therapy 174 181 3156 3163 I-treatment
prior 182 187 3164 3169 O
to 188 190 3170 3172 O
enrollment 191 201 3173 3183 O

Patients 0 8 3184 3192 O
must 9 13 3193 3197 O
not 14 17 3198 3201 O
have 18 22 3202 3206 O
received 23 31 3207 3215 O
prior 32 37 3216 3221 O
exposure 38 46 3222 3230 O
to 47 49 3231 3233 O
selinexor 50 59 3234 3243 B-treatment

Patients 0 8 3244 3252 O
who 9 12 3253 3256 O
have 13 17 3257 3261 O
an 18 20 3262 3264 O
uncontrolled 21 33 3265 3277 B-chronic_disease
infection 34 43 3278 3287 I-chronic_disease

Patients 0 8 3288 3296 O
who 9 12 3297 3300 O
have 13 17 3301 3305 O
received 18 26 3306 3314 O
a 27 28 3315 3316 O
prior 29 34 3317 3322 B-treatment
solid 35 40 3323 3328 I-treatment
organ 41 46 3329 3334 I-treatment
transplantation 47 62 3335 3350 I-treatment

Patients 0 8 3351 3359 O
with 9 13 3360 3364 O
body 14 18 3365 3369 B-bmi
mass 19 23 3370 3374 I-bmi
index 24 29 3375 3380 I-bmi
( 30 31 3381 3382 I-bmi
BMI 31 34 3382 3385 I-bmi
) 34 35 3385 3386 I-bmi
< 36 37 3387 3388 O
3rd 38 41 3389 3392 B-upper_bound
percentile 42 52 3393 3403 I-upper_bound
for 53 56 3404 3407 O
age 57 60 3408 3411 B-age
, 60 61 3411 3412 O
as 62 64 3413 3415 O
defined 65 72 3416 3423 O
by 73 75 3424 3426 O
WHO 76 79 3427 3430 O
criteria 80 88 3431 3439 O
for 89 92 3440 3443 O
patients 93 101 3444 3452 O
1 102 103 3453 3454 B-lower_bound
- 103 104 3454 3455 O
2 104 105 3455 3456 O
years 106 111 3457 3462 O
of 112 114 3463 3465 O
age 115 118 3466 3469 O
and 119 122 3470 3473 O
Centers 123 130 3474 3481 O
for 131 134 3482 3485 O
Disease 135 142 3486 3493 O
Control 143 150 3494 3501 O
and 151 154 3502 3505 O
Prevention 155 165 3506 3516 O
( 166 167 3517 3518 O
CDC 167 170 3518 3521 O
) 170 171 3521 3522 O
criteria 172 180 3523 3531 O
for 181 184 3532 3535 O
patients 185 193 3536 3544 O
> 194 195 3545 3546 O
2 196 197 3547 3548 O
years 198 203 3549 3554 O
of 204 206 3555 3557 O
age 207 210 3558 3561 O

Patients 0 8 3562 3570 O
with 9 13 3571 3575 O
grade 14 19 3576 3581 B-chronic_disease
3 20 21 3582 3583 I-chronic_disease
ataxia 22 28 3584 3590 I-chronic_disease
or 29 31 3591 3593 O
grade 32 37 3594 3599 O
> 38 39 3600 3601 O
1 39 40 3601 3602 B-lower_bound
extrapyramidal 41 55 3603 3617 B-clinical_variable
movement 56 64 3618 3626 I-clinical_variable
disorder 65 73 3627 3635 I-clinical_variable

Patients 0 8 3636 3644 O
with 9 13 3645 3649 O
known 14 19 3650 3655 O
bone 20 24 3656 3660 B-cancer
marrow 25 31 3661 3667 I-cancer
metastatic 32 42 3668 3678 I-cancer
disease 43 50 3679 3686 I-cancer
will 51 55 3687 3691 O
be 56 58 3692 3694 O
eligible 59 67 3695 3703 O
for 68 71 3704 3707 O
study 72 77 3708 3713 O
if 78 80 3714 3716 O
they 81 85 3717 3721 O
meet 86 90 3722 3726 O
the 91 94 3727 3730 O
blood 95 100 3731 3736 O
counts 101 107 3737 3743 O
( 108 109 3744 3745 O
may 109 112 3745 3748 O
receive 113 120 3749 3756 O
transfusions 121 133 3757 3769 B-treatment
provided 134 142 3770 3778 O
they 143 147 3779 3783 O
are 148 151 3784 3787 O
not 152 155 3788 3791 O
known 156 161 3792 3797 O
to 162 164 3798 3800 O
be 165 167 3801 3803 O
refractory 168 178 3804 3814 O
to 179 181 3815 3817 O
red 182 185 3818 3821 O
cell 186 190 3822 3826 O
or 191 193 3827 3829 O
platelet 194 202 3830 3838 B-treatment
transfusions 203 215 3839 3851 I-treatment
) 215 216 3851 3852 O

Patients 0 8 3853 3861 O
with 9 13 3862 3866 O
known 14 19 3867 3872 O
macular 20 27 3873 3880 B-chronic_disease
degeneration 28 40 3881 3893 I-chronic_disease
, 40 41 3893 3894 O
uncontrolled 42 54 3895 3907 O
glaucoma 55 63 3908 3916 B-chronic_disease
, 63 64 3916 3917 O
or 65 67 3918 3920 O
cataracts 68 77 3921 3930 B-chronic_disease

Patients 0 8 3931 3939 O
with 9 13 3940 3944 O
seizure 14 21 3945 3952 B-chronic_disease
disorder 22 30 3953 3961 I-chronic_disease
may 31 34 3962 3965 O
be 35 37 3966 3968 O
enrolled 38 46 3969 3977 O
if 47 49 3978 3980 O
on 50 52 3981 3983 O
anticonvulsants 53 68 3984 3999 B-treatment
and 69 72 4000 4003 O
well 73 77 4004 4008 O
controlled 78 88 4009 4019 O

Peripheral 0 10 4020 4030 O
absolute 11 19 4031 4039 B-clinical_variable
neutrophil 20 30 4040 4050 I-clinical_variable
count 31 36 4051 4056 I-clinical_variable
( 37 38 4057 4058 I-clinical_variable
ANC 38 41 4058 4061 I-clinical_variable
) 41 42 4061 4062 I-clinical_variable
> 43 44 4063 4064 O
= 44 45 4064 4065 O
1000 46 50 4066 4070 B-lower_bound
/ 50 51 4070 4071 I-lower_bound
mm^3 51 55 4071 4075 I-lower_bound

Platelet 0 8 4076 4084 B-clinical_variable
count 9 14 4085 4090 I-clinical_variable
> 15 16 4091 4092 O
= 16 17 4092 4093 O
100,000 18 25 4094 4101 B-lower_bound
/ 25 26 4101 4102 I-lower_bound
mm^3 26 30 4102 4106 I-lower_bound
( 31 32 4107 4108 O
transfusion 32 43 4108 4119 B-treatment
independent 44 55 4120 4131 O
, 55 56 4131 4132 O
defined 57 64 4133 4140 O
as 65 67 4141 4143 O
not 68 71 4144 4147 O
receiving 72 81 4148 4157 O
platelet 82 90 4158 4166 B-treatment
transfusions 91 103 4167 4179 I-treatment
for 104 107 4180 4183 O
at 108 110 4184 4186 O
least 111 116 4187 4192 O
7 117 118 4193 4194 B-lower_bound
days 119 123 4195 4199 I-lower_bound
prior 124 129 4200 4205 I-lower_bound
to 130 132 4206 4208 O
enrollment 133 143 4209 4219 O
) 143 144 4219 4220 O

Pregnant 0 8 4221 4229 B-pregnancy

Serum 0 5 4230 4235 B-clinical_variable
albumin 6 13 4236 4243 I-clinical_variable
> 14 15 4244 4245 O
= 15 16 4245 4246 O
2 17 18 4247 4248 B-lower_bound
g 19 20 4249 4250 I-lower_bound
/ 20 21 4250 4251 I-lower_bound
dL 21 23 4251 4253 I-lower_bound

Serum 0 5 4254 4259 B-clinical_variable
amylase 6 13 4260 4267 I-clinical_variable
= 14 15 4268 4269 O
< 15 16 4269 4270 O
1.5 17 20 4271 4274 B-upper_bound
x 21 22 4275 4276 I-upper_bound
ULN 23 26 4277 4280 I-upper_bound

Serum 0 5 4281 4286 B-clinical_variable
glutamate 6 15 4287 4296 I-clinical_variable
pyruvate 16 24 4297 4305 I-clinical_variable
transaminase 25 37 4306 4318 I-clinical_variable
( 38 39 4319 4320 I-clinical_variable
SGPT 39 43 4320 4324 I-clinical_variable
) 43 44 4324 4325 I-clinical_variable
( 45 46 4326 4327 O
alanine 46 53 4327 4334 B-clinical_variable
aminotransferase 54 70 4335 4351 I-clinical_variable
[ 71 72 4352 4353 I-clinical_variable
ALT 72 75 4353 4356 I-clinical_variable
] 75 76 4356 4357 I-clinical_variable
) 76 77 4357 4358 O
= 78 79 4359 4360 O
< 79 80 4360 4361 O
3 81 82 4362 4363 B-upper_bound
x 83 84 4364 4365 I-upper_bound
ULN 85 88 4366 4369 I-upper_bound
= 89 90 4370 4371 O
135 91 94 4372 4375 B-upper_bound
U 95 96 4376 4377 I-upper_bound
/ 96 97 4377 4378 I-upper_bound
L 97 98 4378 4379 I-upper_bound

Serum 0 5 4380 4385 B-clinical_variable
glutamic 6 14 4386 4394 I-clinical_variable
oxaloacetic 15 26 4395 4406 I-clinical_variable
transaminase 27 39 4407 4419 I-clinical_variable
( 40 41 4420 4421 I-clinical_variable
SGOT 41 45 4421 4425 I-clinical_variable
) 45 46 4425 4426 I-clinical_variable
( 47 48 4427 4428 I-clinical_variable
aspartate 48 57 4428 4437 I-clinical_variable
aminotransferase 58 74 4438 4454 I-clinical_variable
[ 75 76 4455 4456 I-clinical_variable
AST 76 79 4456 4459 I-clinical_variable
] 79 80 4459 4460 I-clinical_variable
) 80 81 4460 4461 I-clinical_variable
= 82 83 4462 4463 O
< 83 84 4463 4464 O
3 85 86 4465 4466 B-upper_bound
x 87 88 4467 4468 I-upper_bound
ULN 89 92 4469 4472 I-upper_bound
= 93 94 4473 4474 I-upper_bound
150 95 98 4475 4478 I-upper_bound
U 99 100 4479 4480 I-upper_bound
/ 100 101 4480 4481 I-upper_bound
L 101 102 4481 4482 I-upper_bound

Serum 0 5 4483 4488 B-clinical_variable
lipase 6 12 4489 4495 I-clinical_variable
= 13 14 4496 4497 O
< 14 15 4497 4498 O
1.5 16 19 4499 4502 B-upper_bound
x 20 21 4503 4504 I-upper_bound
ULN 22 25 4505 4508 I-upper_bound

Stem 0 4 4509 4513 B-treatment
cell 5 9 4514 4518 I-treatment
infusion 10 18 4519 4527 I-treatment
without 19 26 4528 4535 O
TBI 27 30 4536 4539 B-chronic_disease
: 30 31 4539 4540 O
No 32 34 4541 4543 O
evidence 35 43 4544 4552 O
of 44 46 4553 4555 O
active 47 53 4556 4562 O
graft 54 59 4563 4568 B-chronic_disease
vs. 60 63 4569 4572 I-chronic_disease
host 64 68 4573 4577 I-chronic_disease
disease 69 76 4578 4585 I-chronic_disease
and 77 80 4586 4589 O
at 81 83 4590 4592 O
least 84 89 4593 4598 O
56 90 92 4599 4601 B-lower_bound
days 93 97 4602 4606 I-lower_bound
must 98 102 4607 4611 O
have 103 107 4612 4616 O
elapsed 108 115 4617 4624 O
after 116 121 4625 4630 O
transplant 122 132 4631 4641 B-treatment
or 133 135 4642 4644 O
stem 136 140 4645 4649 B-treatment
cell 141 145 4650 4654 I-treatment
infusion 146 154 4655 4663 I-treatment

Total 0 5 4664 4669 B-clinical_variable
bilirubin 6 15 4670 4679 I-clinical_variable
= 16 17 4680 4681 O
< 17 18 4681 4682 O
1.5 19 22 4683 4686 B-upper_bound
x 23 24 4687 4688 I-upper_bound
upper 25 30 4689 4694 I-upper_bound
limit 31 36 4695 4700 I-upper_bound
of 37 39 4701 4703 I-upper_bound
normal 40 46 4704 4710 I-upper_bound
( 47 48 4711 4712 I-upper_bound
ULN 48 51 4712 4715 I-upper_bound
) 51 52 4715 4716 I-upper_bound
for 53 56 4717 4720 O
age 57 60 4721 4724 B-age

at 0 2 4725 4727 O
least 3 8 4728 4733 O
150 9 12 4734 4737 B-lower_bound
days 13 17 4738 4742 I-lower_bound
must 18 22 4743 4747 O
have 23 27 4748 4752 O
elapsed 28 35 4753 4760 O
if 36 38 4761 4763 O
prior 39 44 4764 4769 B-treatment
total 45 50 4770 4775 I-treatment
body 51 55 4776 4780 I-treatment
irradiation 56 67 4781 4792 I-treatment
( 68 69 4793 4794 I-treatment
TBI 69 72 4794 4797 I-treatment
) 72 73 4797 4798 I-treatment
, 73 74 4798 4799 O
craniospinal 75 87 4800 4812 B-treatment
XRT 88 91 4813 4816 I-treatment
or 92 94 4817 4819 O
if 95 97 4820 4822 O
> 98 99 4823 4824 O
= 99 100 4824 4825 O
50 101 103 4826 4828 B-lower_bound
% 103 104 4828 4829 I-lower_bound
radiation 105 114 4830 4839 O
of 115 117 4840 4842 O
pelvis 118 124 4843 4849 O

at 0 2 4850 4852 O
least 3 8 4853 4858 O
42 9 11 4859 4861 B-lower_bound
days 12 16 4862 4866 I-lower_bound
must 17 21 4867 4871 O
have 22 26 4872 4876 O
elapsed 27 34 4877 4884 O
if 35 37 4885 4887 O
other 38 43 4888 4893 O
substantial 44 55 4894 4905 O
bone 56 60 4906 4910 B-treatment
marrow 61 67 4911 4917 I-treatment
( 68 69 4918 4919 I-treatment
BM 69 71 4919 4921 I-treatment
) 71 72 4921 4922 I-treatment
radiation 73 82 4923 4932 I-treatment

at 0 2 4933 4935 O
least 3 8 4936 4941 O
5 9 10 4942 4943 B-lower_bound
of 11 13 4944 4946 O
every 14 19 4947 4952 O
cohort 20 26 4953 4959 O
of 27 29 4960 4962 O
6 30 31 4963 4964 O
patients 32 40 4965 4973 O
must 41 45 4974 4978 O
be 46 48 4979 4981 O
evaluable 49 58 4982 4991 O
for 59 62 4992 4995 O
hematologic 63 74 4996 5007 O
toxicity 75 83 5008 5016 O
for 84 87 5017 5020 O
the 88 91 5021 5024 O
dose 92 96 5025 5029 O
- 96 97 5029 5030 O
escalation 97 107 5030 5040 O
part 108 112 5041 5045 O
of 113 115 5046 5048 O
the 116 119 5049 5052 O
study 120 125 5053 5058 O

breast 0 6 5059 5065 O
- 6 7 5065 5066 O
feeding 7 14 5066 5073 O
women 15 20 5074 5079 B-gender

for 0 3 5080 5083 O
agents 4 10 5084 5090 O
that 11 15 5091 5095 O
have 16 20 5096 5100 O
known 21 26 5101 5106 O
adverse 27 34 5107 5114 O
events 35 41 5115 5121 O
occurring 42 51 5122 5131 O
beyond 52 58 5132 5138 O
7 59 60 5139 5140 B-lower_bound
days 61 65 5141 5145 I-lower_bound
after 66 71 5146 5151 O
administration 72 86 5152 5166 O
, 86 87 5166 5167 O
this 88 92 5168 5172 O
period 93 99 5173 5179 O
must 100 104 5180 5184 O
be 105 107 5185 5187 O
extended 108 116 5188 5196 O
beyond 117 123 5197 5203 O
the 124 127 5204 5207 O
time 128 132 5208 5212 O
during 133 139 5213 5219 O
which 140 145 5220 5225 O
adverse 146 153 5226 5233 O
events 154 160 5234 5240 O
are 161 164 5241 5244 O
known 165 170 5245 5250 O
to 171 173 5251 5253 O
occur 174 179 5254 5259 O

for 0 3 5260 5263 O
agents 4 10 5264 5270 O
that 11 15 5271 5275 O
have 16 20 5276 5280 O
known 21 26 5281 5286 O
adverse 27 34 5287 5294 O
events 35 41 5295 5301 O
occurring 42 51 5302 5311 O
beyond 52 58 5312 5318 O
7 59 60 5319 5320 B-lower_bound
days 61 65 5321 5325 I-lower_bound
after 66 71 5326 5331 I-lower_bound
administration 72 86 5332 5346 O
, 86 87 5346 5347 O
this 88 92 5348 5352 O
period 93 99 5353 5359 O
must 100 104 5360 5364 O
be 105 107 5365 5367 O
extended 108 116 5368 5376 O
beyond 117 123 5377 5383 O
the 124 127 5384 5387 O
time 128 132 5388 5392 O
during 133 139 5393 5399 O
which 140 145 5400 5405 O
adverse 146 153 5406 5413 O
events 154 160 5414 5420 O
are 161 164 5421 5424 O
known 165 170 5425 5430 O
to 171 173 5431 5433 O
occur 174 179 5434 5439 O
; 179 180 5439 5440 O
the 181 184 5441 5444 O
duration 185 193 5445 5453 O
of 194 196 5454 5456 O
this 197 201 5457 5461 O
interval 202 210 5462 5470 O
must 211 215 5471 5475 O
be 216 218 5476 5478 O
discussed 219 228 5479 5488 O
with 229 233 5489 5493 O
the 234 237 5494 5497 O
study 238 243 5498 5503 O
chair 244 249 5504 5509 O

for 0 3 5510 5513 O
the 4 7 5514 5517 O
purpose 8 15 5518 5525 O
of 16 18 5526 5528 O
this 19 23 5529 5533 O
study 24 29 5534 5539 O
, 29 30 5539 5540 O
the 31 34 5541 5544 O
ULN 35 38 5545 5548 O
for 39 42 5549 5552 O
SGOT 43 47 5553 5557 B-clinical_variable
is 48 50 5558 5560 O
50 51 53 5561 5563 B-upper_bound
U 54 55 5564 5565 I-upper_bound
/ 55 56 5565 5566 I-upper_bound
L 56 57 5566 5567 I-upper_bound

for 0 3 5568 5571 O
the 4 7 5572 5575 O
purpose 8 15 5576 5583 O
of 16 18 5584 5586 O
this 19 23 5587 5591 O
study 24 29 5592 5597 O
, 29 30 5597 5598 O
the 31 34 5599 5602 O
ULN 35 38 5603 5606 O
for 39 42 5607 5610 O
SGPT 43 47 5611 5615 B-clinical_variable
is 48 50 5616 5618 O
45 51 53 5619 5621 O
U 54 55 5622 5623 O
/ 55 56 5623 5624 O
L 56 57 5624 5625 O

males 0 5 5626 5631 B-gender
or 6 8 5632 5634 I-gender
females 9 16 5635 5642 I-gender
of 17 19 5643 5645 O
reproductive 20 32 5646 5658 O
potential 33 42 5659 5668 O
may 43 46 5669 5672 O
not 47 50 5673 5676 O
participate 51 62 5677 5688 O
unless 63 69 5689 5695 O
they 70 74 5696 5700 O
have 75 79 5701 5705 O
agreed 80 86 5706 5712 B-contraception_consent
to 87 89 5713 5715 I-contraception_consent
use 90 93 5716 5719 I-contraception_consent
an 94 96 5720 5722 I-contraception_consent
effective 97 106 5723 5732 I-contraception_consent
contraceptive 107 120 5733 5746 I-contraception_consent
use 121 124 5747 5750 I-contraception_consent
two 125 128 5751 5754 I-contraception_consent
effective 129 138 5755 5764 I-contraception_consent
methods 139 146 5765 5772 I-contraception_consent
of 147 149 5773 5775 I-contraception_consent
birth 150 155 5776 5781 I-contraception_consent
control- 156 164 5782 5790 I-contraception_consent
including 165 174 5791 5800 O
a 175 176 5801 5802 O
medically 177 186 5803 5812 O
accepted 187 195 5813 5821 O
barrier 196 203 5822 5829 B-contraception_consent
method 204 210 5830 5836 I-contraception_consent
of 211 213 5837 5839 I-contraception_consent
contraceptive 214 227 5840 5853 I-contraception_consent
method 228 234 5854 5860 I-contraception_consent
( 235 236 5861 5862 O
e.g. 236 240 5862 5866 O
, 240 241 5866 5867 O
male 242 246 5868 5872 B-gender
or 247 249 5873 5875 I-gender
female 250 256 5876 5882 I-gender
condom 257 263 5883 5889 B-contraception_consent
) 263 264 5889 5890 O
for 265 268 5891 5894 O
the 269 272 5895 5898 O
entire 273 279 5899 5905 O
period 280 286 5906 5912 O
in 287 289 5913 5915 O
which 290 295 5916 5921 O
they 296 300 5922 5926 O
are 301 304 5927 5930 O
receiving 305 314 5931 5940 O
protocol 315 323 5941 5949 B-treatment
therapy 324 331 5950 5957 I-treatment

patients 0 8 5958 5966 O
must 9 13 5967 5971 O
have 14 18 5972 5976 O
had 19 22 5977 5980 O
histologic 23 33 5981 5991 O
verification 34 46 5992 6004 O
of 47 49 6005 6007 O
malignancy 50 60 6008 6018 B-cancer
at 61 63 6019 6021 O
original 64 72 6022 6030 O
diagnosis 73 82 6031 6040 O
or 83 85 6041 6043 O
relapse 86 93 6044 6051 O

patients 0 8 6052 6060 O
must 9 13 6061 6065 O
have 14 18 6066 6070 O
had 19 22 6071 6074 O
histologic 23 33 6075 6085 O
verification 34 46 6086 6098 O
of 47 49 6099 6101 O
malignancy 50 60 6102 6112 B-cancer
at 61 63 6113 6115 O
original 64 72 6116 6124 O
diagnosis 73 82 6125 6134 O
or 83 85 6135 6137 O
relapse 86 93 6138 6145 O
except 94 100 6146 6152 O
in 101 103 6153 6155 O
patients 104 112 6156 6164 O
with 113 117 6165 6169 O
intrinsic 118 127 6170 6179 O
brain 128 133 6180 6185 B-cancer
stem 134 138 6186 6190 I-cancer
tumors 139 145 6191 6197 I-cancer
, 145 146 6197 6198 O
optic 147 152 6199 6204 B-cancer
pathway 153 160 6205 6212 I-cancer
gliomas 161 168 6213 6220 I-cancer
, 168 169 6220 6221 O
or 170 172 6222 6224 O
patients 173 181 6225 6233 O
with 182 186 6234 6238 O
pineal 187 193 6239 6245 B-cancer
tumors 194 200 6246 6252 I-cancer
and 201 204 6253 6256 O
elevations 205 215 6257 6267 O
of 216 218 6268 6270 O
cerebrospinal 219 232 6271 6284 O
fluid 233 238 6285 6290 O
( 239 240 6291 6292 O
CSF 240 243 6292 6295 O
) 243 244 6295 6296 O
or 245 247 6297 6299 O
serum 248 253 6300 6305 O
tumor 254 259 6306 6311 O
markers 260 267 6312 6319 O
including 268 277 6320 6329 O
alpha 278 283 6330 6335 O
- 283 284 6335 6336 O
fetoprotein 284 295 6336 6347 O
or 296 298 6348 6350 O
beta 299 303 6351 6355 O
- 303 304 6355 6356 O
human 304 309 6356 6361 O
chorionic 310 319 6362 6371 O
gonadotropin 320 332 6372 6384 O
( 333 334 6385 6386 O
HCG 334 337 6386 6389 O
) 337 338 6389 6390 O

pregnancy 0 9 6391 6400 B-pregnancy
tests 10 15 6401 6406 O
must 16 20 6407 6411 O
be 21 23 6412 6414 O
obtained 24 32 6415 6423 O
in 33 35 6424 6426 O
girls 36 41 6427 6432 O
who 42 45 6433 6436 O
are 46 49 6437 6440 O
post 50 54 6441 6445 O
- 54 55 6445 6446 O
menarchal 55 64 6446 6455 O

